| 引用本文: | 别春晓,苏昱霖,陈玉文.中国医药制造业子行业研发投入相关因素的实证分析[J].中国现代应用药学,2016,33(8):1078-1082. |
| BIE Chunxiao,SU Yulin,CHEN Yuwen.Empirical Analysis on Related Factors of R&D Investment of Sub-industry of China’s Pharmaceutical Manufacturing Industry[J].Chin J Mod Appl Pharm(中国现代应用药学),2016,33(8):1078-1082. |
|
| 摘要: |
| 目的 为有效提升中国医药制造业子行业的研发投入水平提供参考。方法 基于2005—2013年化学药品制造业、中成药制造业和生物药品制造业经济和研发情况的调查数据，使用因子分析回归方法，实证分析企业规模、盈利能力、研发人力资本、研发知识产出、行业中企业竞争程度、新产品市场需求等因素对各医药子行业研发投入的影响。结果 企业规模、行业盈利水平、研发人力资本、研发知识产出、行业中企业竞争程度、新产品市场需求与化学药品制造业、中成药制造业的研发投入均呈正相关关系。对生物药品制造业来说，企业规模、行业盈利水平、研发人力资本、研发知识产出、行业中企业竞争程度与研发投入均表现为正相关关系；新产品市场需求与生物制药行业的研发投入呈显著负相关。结论 扩大企业规模、提高盈利水平、增加研发人力、增多研发知识产出、合理引导企业参与竞争、适当拓展新产品市场需求可明显提高医药制造业子行业研发投入水平。 |
| 关键词: 医药制造业 子行业 研发投入 影响因素 因子分析回归 |
| DOI： |
| 分类号: |
| 基金项目:“重大新药创制”国家科技重大专项(2013ZX09301305) |
|
| Empirical Analysis on Related Factors of R&D Investment of Sub-industry of China’s Pharmaceutical Manufacturing Industry |
|
BIE Chunxiao, SU Yulin, CHEN Yuwen
|
|
College of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
|
| Abstract: |
| OBJECTIVE To provide a reference for effectively enhancing the level of R&D investment of sub-industry of China’s pharmaceutical manufacturing industry. METHODS The thesis empirically analyzed the relationship between firm sizes, profitability, R&D personnel, R&D knowledge outputs, the degree of competition of enterprises, marketing demand for new products and the R&D investment of sub-industry of pharmaceutical manufacturing industry, based on 2005-2013 survey data of research and development conditions and economic conditions of sub-industry of pharmaceutical manufacturing industry and with the use of factor analysis regression. RESULTS Firm sizes, the profitability in the industry, R&D personnel, R&D knowledge outputs, the degree of competition of enterprises, marketing demand for new products were positively correlated with R&D expenditure of chemical medicine manufacturing industry and Chinese medicine industry. And firm sizes, the profitability in the industry, R&D personnel, R&D knowledge outputs, the degree of competition of enterprises were positively correlated with R&D expenditure of bio-pharmaceutical manufacturing industry, while marketing demand for new products were negatively correlated with R&D expenditure of bio-pharmaceutical manufacturing industry. CONCLUSION Expanding firm sizes, increasing the profitability, R&D personnel, R&D knowledge outputs, reasonably guiding enterprises to participate in competition, reasonably developing marketing demands of new products can significantly improve the R&D investment of sub-industry of pharmaceutical manufacturing. |
| Key words: pharmaceutical manufacturing industry sub-industry R&D investment factors factor analysis regression |
